RT Kevin Chau (@kchau)Schwab phone numbers:General: (877) 566-4945Private Client: (866) 855-9102I just got off the phone with @CharlesSchwab. If you hold assets at Schwab, please call this number and tell them you are unhappy with their proxy vote for Tesla in their ETFs. Please tell them to send a message up the chain to the proxy team and the advocacy team to “change their vote to be aligned with the Board”. Also tell them to reject the guidance of GlassLewis.The ETFs in question are - make sure they take ...

Core Viewpoint - Analysts project a 10.55% upside for the Schwab 1000 Index ETF (SCHK) based on the average target prices of its underlying holdings, indicating potential growth in the ETF's value [1][2]. Summary by Category ETF Performance - The Schwab 1000 Index ETF (SCHK) is currently trading at $31.75 per unit, with an implied analyst target price of $35.10 per unit, suggesting a potential upside of 10.55% [2][3]. Underlying Holdings - Notable underlying holdings with significant upside potential include: - QXO Inc (Symbol: QXO) with a recent price of $20.77 and an average analyst target of $33.73, representing a 62.38% upside [2][3]. - SPS Commerce, Inc. (Symbol: SPSC) trading at $105.53, with a target price of $157.54, indicating a 49.29% upside [2][3]. - BridgeBio Pharma Inc (Symbol: BBIO) at a recent price of $51.21, with a target of $64.67, showing a 26.28% upside [2][3]. Analyst Target Justification - Questions arise regarding whether analysts' targets are justified or overly optimistic, considering recent company and industry developments. A high target relative to current trading prices may reflect optimism but could also lead to potential downgrades if targets are outdated [3].